reviewTop 1% cited
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
European Urology · 2019 · Vol. 76(5) · pp. 639–657
Marko Babjuk✉(Charles University)Maximilian Burger(University of Regensburg)Éva Compérat(Sorbonne Université)Paolo Gontero(Fondazione Ricerca Molinette)Hugh Mostafid(Royal Surrey County Hospital)Joan Palou(Universitat Autònoma de Barcelona)Bas W.G. van Rhijn(The Netherlands Cancer Institute)Morgan Rouprêt(Sorbonne Université)Shahrokh F. Shariat(Sechenov University)Richard SylvesterRichard Zigeuner(Medical University of Graz)Otakar Čapoun(Charles University)Daniel L. Cohen(Royal Free London NHS Foundation Trust)J.L. Domínguez Escrig(Fundación Instituto Valenciano de Oncología)Virginia Hernández(Hospital Universitario Fundación Alcorcón)B. Peyronnet(Centre Hospitalier Universitaire de Rennes)Thomas Seisen(Sorbonne Université)Viktor Soukup(Charles University)
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and TreatmentsMedicineCystoscopyBladder cancerCarcinoma in situUrologyMEDLINECarcinomaCancerInternal medicineOncology
MeSH terms
Urinary Bladder NeoplasmsEuropeHumansNeoplasm InvasivenessNeoplasm StagingPatient Care ManagementSocieties, MedicalUrologyPractice Guidelines as Topic
Citations
1,294
FWCI
207.19
field-weighted impact
References
156
Percentile
100%
vs. same field & year
Citations per year
References
Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer
The Journal of Urology · 1992 · 786 citations
Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
Urology · 2004 · 458 citations
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
European Urology · 2006 · 2,943 citations
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
The Journal of Urology · 2016 · 1,534 citations
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
The Journal of Urology · 2002 · 1,296 citations
Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies
European Urology · 2002 · 678 citations
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
European Urology · 2009 · 650 citations
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
The Journal of Urology · 2000 · 1,298 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.